LETROZOLE is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Chartwell Rx, Llc. The primary component is Letrozole.
| Product ID | 62135-491_d630a1ee-a57d-3170-e053-2995a90a9d50 |
| NDC | 62135-491 |
| Product Type | Human Prescription Drug |
| Proprietary Name | LETROZOLE |
| Generic Name | Letrozole |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-05-09 |
| Marketing Category | ANDA / |
| Application Number | ANDA205869 |
| Labeler Name | Chartwell RX, LLC |
| Substance Name | LETROZOLE |
| Active Ingredient Strength | 3 mg/1 |
| Pharm Classes | Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-01-17 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0093-7620 | Letrozole | Letrozole |
| 16729-034 | Letrozole | letrozole |
| 17856-0032 | Letrozole | letrozole |
| 24535-0801 | LETROZOLE | LETROZOLE |
| 24724-030 | LETROZOLE | LETROZOLE |
| 42254-243 | Letrozole | Letrozole |
| 42291-374 | Letrozole | Letrozole |
| 50090-3474 | Letrozole | letrozole |
| 50268-476 | LETROZOLE | LETROZOLE |
| 51991-759 | LETROZOLE | LETROZOLE |
| 55111-646 | Letrozole | Letrozole |
| 57884-2021 | LETROZOLE | LETROZOLE |
| 59651-180 | Letrozole | Letrozole |
| 60505-3255 | Letrozole | Letrozole |
| 62135-491 | LETROZOLE | Letrozole |
| 62756-511 | LETROZOLE | LETROZOLE |
| 63629-7819 | Letrozole | letrozole |
| 63850-0025 | Letrozole | Letrozole |
| 65841-744 | letrozole | letrozole |
| 68071-5264 | Letrozole | letrozole |
| 68084-803 | Letrozole | Letrozole |
| 68382-363 | letrozole | letrozole |
| 69117-0004 | Letrozole | Letrozole Tablets |
| 70518-1869 | Letrozole | Letrozole |
| 70518-2020 | Letrozole | Letrozole |
| 71335-1526 | LETROZOLE | LETROZOLE |
| 0078-0249 | Femara | letrozole |